Projects per year
Dr Geoff Coxon is a lecturer in Medicinal Chemistry. After receiving his PhD from the University of Newcastle upon Tyne, and a short term industry, he moved SIPBS where he set up his research group in the discovery and development of new agents to treat tuberculosis. He is the co-founder and Deputy Leader of TB Drug Discovery UK (www.tbd-uk.org.uk). In this role he works with fellow scientists and clinicians, UK government policy makers and advocates with the goal of strengthening scientific research across all areas of TB drug development as a key part of the UK response in the global eradiation of the disease.
- 2 Finished
Resistance to thiacetazone derivatives active against Mycobacterium abscessus involves mutations in the MmpL5 transcriptional repressor MAB_4384Halloum, I., Viljoen, A., Khanna, V., Craig, D., Bouchier, C., Brosch, R., Coxon, G. & Kremer, L., 30 Apr 2017, In: Antimicrobial Agents and Chemotherapy . 61, 4, p. e02509-16:1-14 14 p., e02509-16.
Research output: Contribution to journal › Conference Contribution › peer-reviewOpen AccessFile
Kardar, M. N., Zhang, T., Coxon, G. D., Watson, D. G., Fearnley, J. & Seidel, V., 1 Oct 2014, In: Phytochemistry. 106, p. 156-163 8 p.
Research output: Contribution to journal › Article › peer-reviewOpen AccessFile
- 2 Key-note speaker and plenary lectures at conferences